Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

22 Results

Guidelines and Advice

An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

Status: In-Review
ID: GL END 3-23
Version: N/A

Oct 2021

Guidelines and Advice

Enhancing the Delivery of Take-Home Cancer Drugs in Ontario

Status: Current

Mar 2019

Guidelines and Advice

Active Surveillance for the Management of Localized Prostate Cancer

Status: In-Review
ID: 17-9

Dec 2014

Guidelines and Advice

Optimal Systemic Therapy for Early Female Breast Cancer

Status: In-Review
ID: 1-21

Sep 2014

Guidelines and Advice

Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma

Status: In-Review
ID: 4-8
Version: 4

Jul 2019

Guidelines and Advice

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

Status: Archived
ID: 1-18

May 2012

Guidelines and Advice

Recombinant Humanized Thyroid Stimulating Hormone (rhTSH) Preparation Prior To Radioiodine Ablation in Patients Who Have Undergone Thyroidectomy for Papillary or Follicular Thyroid Cancer

Status: Archived
ID: CED 5

May 2007

Guidelines and Advice

Adjuvant Hormonal Therapy for Stage I Endometrial Cancer

Status: Archived
ID: 4-14

Oct 2007

Guidelines and Advice

Adjuvant Systemic Therapy for Node-negative Breast Cancer

Status: Archived
ID: 1-8

Sep 2011

Guidelines and Advice

Cancer Care Ontario Thyroid Cancer Guideline: An Endorsement of the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Status: Current
ID: GL END 5-13
Version: N/A

Jun 2023

Pages